Summit Therapeutics Inc. (SMMT)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

17.86

-0.17%

After-hours Dec 13, 2024, 07:09 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03
Revenue	-	704.29K	1.81M	860.00K	632.02K	56.41M	35.98M	2.88M	-	2.27M	2.27M	2.87M	2.77M	1.21M	301.94K	266.64K	6.03M	2.03M	947.89K	212.76K	1.82K
Cost of Revenue	2.05M	2.51M	-	-	155.40K	24.92K	97.67K	-	-	-	-	-	1.01M	-	-	5.77K	2.51M	596.30K	415.93K	169.46K	1.82K
Gross Profit	-2.05M	-1.81M	1.81M	860.00K	476.62K	56.39M	35.88M	2.88M	-	2.27M	2.27M	2.87M	1.76M	1.21M	301.94K	260.87K	3.51M	1.43M	531.96K	43.30K	-
Operating Income	-89.74M	-72.09M	-86.19M	-53.19M	-42.76M	12.38M	-18.25M	-31.07M	-28.73M	-19.15M	-11.07M	-7.23M	-4.71M	-9.38M	-9.20M	-19.20M	-23.40M	-8.60M	-3.21M	-536.61K	-43.79K
Interest Income	10.40M	1.51M	178.95K	4.00K	4.34K	3.66M	4.38M	10.00K	30.00K	-	14.85K	17.37K	10.99K	26.90K	12.78K	430.95K	1.54M	1.72M	1.04M	404.81K	1.82K
Pretax Income	-615.87M	-78.78M	-88.60M	-52.91M	-28.41M	6.60M	-15.42M	-32.13M	-28.69M	-19.07M	-11.05M	-7.21M	-4.71M	-9.36M	-9.30M	-18.88M	-21.94M	-6.88M	-2.17M	-131.80K	-41.96K
Net Income	-614.93M	-74.38M	-86.15M	-52.70M	-23.88M	9.87M	-10.09M	-26.71M	-24.34M	-17.12M	-10.05M	-6.67M	-4.23M	-7.42M	-8.66M	-32.29M	-20.13M	-5.92M	-1.89M	-86.61K	-41.96K
Selling & General & Admin	28.21M	26.70M	23.61M	19.23M	9.30M	16.19M	16.98M	10.35M	7.45M	6.80M	3.24M	2.77M	2.31M	2.68M	4.20M	5.03M	7.31M	1.86M	1.79M	75.31K	43.79K
Research & Development	59.47M	52.00M	85.35M	53.27M	32.71M	51.38M	41.01M	23.69M	23.94M	15.64M	10.83M	5.72M	4.78M	3.66M	3.68M	7.38M	15.34M	5.79M	1.83M	504.60K	-
Other Expenses	-	-14.42M	-20.97M	-19.31M	-	-19.88M	-3.86M	-1.95M	-3.14M	-682.90K	-682.90K	18.95K	339.19K	-10.32M	3.48M	2.97M	2.70M	2.37M	119.60K	-	-1.82K
Operating Expenses	87.69M	64.28M	88.00M	53.19M	42.00M	47.69M	54.13M	33.94M	29.45M	19.29M	13.33M	8.51M	7.45M	5.55M	9.49M	15.43M	26.92M	10.03M	3.74M	579.92K	43.79K
Interest Expense	16.46M	4.40M	281.00K	255.00K	32.52K	556.10K	1.65M	1.08M	-	448.00K	-	-	4.71K	6.33K	107.04K	116.74K	75.56K	11.77K	-	-	-
Selling & Marketing Expenses	-2.05M	-	-	-	2.06M	-	-	-	-	-	-	-	-	-	372.24K	1.12M	2.17M	1.00M	-	-	-
Cost & Expenses	89.74M	64.28M	88.00M	53.19M	43.40M	47.69M	54.13M	33.94M	29.45M	19.29M	13.33M	8.51M	7.45M	5.55M	9.49M	15.43M	29.43M	10.62M	4.16M	749.37K	45.61K
Income Tax	-946.00K	-4.40M	-2.46M	-213.00K	-4.52M	-3.27M	-5.32M	-5.42M	-4.36M	-1.95M	-1.00M	-538.61K	-477.37K	-1.94M	-594.31K	-2.52M	-1.81M	-959.18K	-278.48K	-45.19K	-1.82K
Shares Outstanding (Basic)	619.65M	193.34M	92.24M	69.52M	164.15M	86.14M	65.03M	61.55M	59.10M	39.60M	4.83M	15.81M	177.88M	166.29M	67.01M	53.39M	47.90M	36.42M	31.31M	23.46M	19.02M
Shares Outstanding (Diluted)	619.65M	193.34M	92.24M	69.52M	164.15M	86.14M	65.43M	61.55M	59.10M	39.60M	4.83M	15.81M	177.88M	166.29M	67.01M	53.39M	47.90M	36.42M	31.31M	23.46M	19.02M
EPS (Basic)	-0.99	-0.38	-0.93	-0.76	-0.15	0.11	-0.16	-0.43	-0.41	-0.43	-2.08	-0.42	-0.02	-0.04	-0.13	-0.6	-0.42	-0.16	-0.06	-0.00	-0.00
EPS (Diluted)	-0.99	-0.38	-0.93	-0.76	-0.15	0.11	-0.15	-0.43	-0.41	-0.43	-2.08	-0.42	-0.02	-0.04	-0.13	-0.6	-0.42	-0.16	-0.06	-0.00	-0.00
EBITDA	1.00M	-52.63M	-62.74M	-37.13M	-16.80M	11.65M	-32.19M	-30.98M	-20.30M	-12.20M	-11.02M	-5.48M	-4.41M	-8.65M	-5.41M	-16.03M	-18.58M	-6.13M	-2.97M	-527.20K	-41.96K
Depreciation & Amortization	90.74M	2.51M	2.46M	2.00M	1.39M	1.49M	348.20K	72.50K	68.36K	49.72K	42.89K	146.89K	295.22K	710.54K	3.78M	2.74M	3.28M	737.53K	240.99K	9.41K	1.82K